Combination therapy promising against blindness-causing bacterial keratitis On 2018-11-12 Multidrug-resistant bacterial infections of the cornea are a leading cause of blindness and cannot be effectively managed with current ophthalmic […]
FDA Approves First Drug for Neurotrophic Keratitis On 2018-08-24 THURSDAY, Aug. 23, 2018 — Oxervate (cenegermin) has been approved by the U.S. Food and Drug Administration to treat neurotrophic […]